Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing Glutamatergic Changes as the Mechanism of Action in the Rapid Antidepressant Effects of Ketamine

NCT06788249 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT06788249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06788249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing Glutamatergic Changes as the Mechanism of Action in the Rapid Antidepressant Effects of Ketamine
Lead sponsor
University of Pennsylvania
Phase
Phase 1
Overall status
Recruiting
Start date
April 1, 2026
Completion date
December 15, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd)